alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
RIZEBEL LOUISSAINT,

Appellant,

v.

FLORIDA DEPARTMENT OF 

REVENUE and LIMUDE PIERRE, 

Appellees.

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D15-1208

_____________________________/

Opinion filed December 8, 2015.

An appeal from an order of the Department of Revenue.

Rizebel Louissaint, pro se, Appellant.

Pamela Jo Bondi, Attorney General, and Toni C. Bernstein, Senior Assistant 

Attorney General, Tallahassee, for Appellee Department of Revenue.

PER CURIAM.

AFFIRMED.

ROBERTS, C.J., BENTON, and KELSEY, JJ., CONCUR.
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

UNITED STATES OF AMERICA,

Plaintiff

- Appellee,

v.

MATHEW DOUGLAS WINCHELL,

Defendant

- Appellant. No. 16

- 30 067

D.C. No. 4:02

- cr

- 00108

- SEH

MEMORANDUM *

Appeal from the United States District Court

for the District of Montana

Sam E. Haddon, District Judge, Presiding

Submitted February 1 4, 2017 **

Before: GOODWIN, FARRIS, and FERNANDEZ, Circuit Judges.

Mathew Douglas Winchell appeals from the district court’s o rder denying

his motion for a sentence reduction under 18 U.S.C. § 3582(c)(2). We have

jurisdiction under 28 U.S.C. § 1291 , and we affirm

.

* This disposition is not appropriate for publication and is not precedent

except as provided by Ninth Circuit Rule 36

- 3.

** The panel unanimously concludes this case is suitable for decision

without oral argument. See Fed. R. App. P. 34(a)(2). Appellant’s request for oral

argument is denied. 

# FILED

FEB 22 2017

MOLLY C. DWYER, CLER K

U.S. COURT OF APPEAL S2 16

- 30067

Winchell contends that the district court abused its discretion by declining to

reduce his sentence under Amendmen t 782 to the Sentencing Guidelines. The

district court acted within its discretion when it denied Winchell a sentence

reduction based on the large quantities of drugs he supplied over a long period of

time, his managerial role in the drug distribution ent erprise, and the fact that h e

engaged in illegal activity in the presence of children

. See U.S.S.G. § 1B1.10 cmt.

n .1(B); United States v. Lightfoot , 626 F.3d 1095

- 96 , 1096 (9th Cir. 2010).

Furthermore, notwithstanding the court’s failure to specifically address Winchell’s

argument concerning his post

- offense conduct, the court’s explanation of its denial

was sufficient. See United States v. Carty , 520 F.3d 984, 992 (9th Cir. 2008) (en

banc).

AFFIRMED

.
Exhibit 23.4







VIA SEDAR / EDGAR



Ontario Securities Commission, as Principal Regulator

British Columbia Securities Commission

Alberta Securities Commission

United States Securities and Exchange Commission



Dear Sirs/Mesdames:



| | Re: | Sierra Metals Inc. (the “Company”)
| | --- | ----------------------------------

Annual Information Form
for the Company’s fiscal year ended December 31, 2017, incorporated by reference into the Company’s Prospectus Supplement
dated October 10, 2017 to the Short Form Base Shelf Prospectus dated June 29, 2017 (the “Prospectus Supplement”) and
the Annual Report incorporated by reference into the Company’s registration statement on Form F-10 (Registration No. 333-218076)
(the “Registration Statement”)

Consent of Qualified Person



Reference is made to the Annual Report
on Form 40-F for the fiscal year ended December 31, 2017 of the Company (the “Form 40-F”), filed with the United
States Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended. Reference is also made to
the Annual Information Form of the Company for the year ended December 31, 2017 (the “AIF”), and its incorporation
by reference: (i) into the Prospectus Supplement, and (ii) as an exhibit to and incorporated by reference into the Form 40-F.



I hereby consent to the: (i) inclusion
of each of the summary section of the report entitled “NI 43-101 Technical Report on Resources and Reserves, Yauricocha
Mine, Yauyos Province, Peru” dated effective July 31, 2017 (the “Yauricocha Technical Report”), and
the summary section of the report entitled “NI 43-101 Technical Report on Resources and Reserves, Bolivar Mine, Mexico”
dated effective February 28, 2017 (the “Bolivar Technical Report”) in the AIF and any amendments thereto, and
the incorporation of such reports in the AIF, (ii) incorporation of the AIF in the Form 40-F and any amendments thereto, and in
the Company's Registration Statement, including the prospectus contained therein, as amended or supplemented, (iii) incorporation
by reference of the AIF and any amendments thereto, into the Prospectus Supplement and (iv) being named in, and the use of the
Yauricocha Technical Report and the Bolivar Technical Report or portions thereof prepared, reviewed and/or approved by me, in the
AIF and Form 40-F.



I also hereby confirm that I have read
the AIF and have no reason to believe that there are any misrepresentations in the information contained therein that are derived
from the Yauricocha Technical Report or the Bolivar Technical Report or within my knowledge as a result of the services I performed
in connection with the Yauricocha Technical Report or the Bolivar Technical Report.





[Signature page follows]



1







Dated: March 22, 2018



|/s/ Jeff Osborn                  | 
|-------------------------------- | 
|Jeff Osborn, BEng Mining, MMSAQP | 





2
1/7/15 Page of



### STANDARD REVIEW EXPOSURE REPORT Summary Page

Chemical ID: P-15-0025 Re viewe r: Wong/BC

Endpoints- Assessed Table

Endpoints/Assessment Cycles 1 Releases

Assessed in

NCEM2? Reasons for not assessing releases

No XB Testing Required No

Hazard

Concern No

Releases Release

Below

Acute

Threshold 5 Release

Below

Chronic

Threshold 5 Other

Ingestion

Surface water Ground water (landfill)

Consumer Use: DtD 2

Inhalation Air: incineration (stack) Air: fugitive

Consumer Use: CEM 3

Dermal

Consumer Use: CEM

Eco

Surface water: ADR

conc and/or PDM 4

Consumer Use: DtD

1 Assessment cycles are endpoint concentrations and dose calculations within the NCEM2 model.

2 Down

- the

- Drain

3 Consumer Exposure Model

4 Probabilistic Dilution Model

5 The threshold values for assessing endpoints are 1 mg/day for acute doses and 1 mg/year for chronic doses.

EAB DROP: Release information for this compound do es not meet criteria for preparation of an exposure assessment in the Exposure Assessment Branch = s (EAB) Initial Review Exposure Report (this report).
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 04-7708

JOEL BRUCE SCHOONOVER, Plaintiff - Appellant, versus DAVID H. WILMOTH, Defendant - Appellee. Appeal from the United States District Court for the Northern District of West Virginia, at Elkins. Robert E. Maxwell, Senior District Judge. (CA-04-44-2) Submitted: February 9, 2005 Decided: February 17, 2005 Before WILKINSON, MICHAEL, and SHEDD, Circuit Judges. Affirmed by unpublished per curiam opinion. Joel Bruce Schoonover, Appellant Pro Se. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).- 2 - PER CURIAM: Joel Bruce Schoonover appeals the district court’s order dismissing his 42 U.S.C. § 1983 (2000) complaint. The district court referred this case to a magistrate judge pursuant to 28 U.S.C. § 636(b)(1)(B) (2000). The magistrate judge recommended that relief be denied and advised Schoonover that failure to file timely objections to this recommendation could waive appellate review of a district court order based upon the recommendation. Despite this warning, Schoonover failed to object to the magistrate judge’s recommendation. The timely filing of specific objections to a magistrate judge’s recommendation is necessary to preserve appellate review of the substance of that recommendation when the parties have been warned that failure to object will waive appellate review. See Wright v. Collins , 766 F.2d 841, 845-46 (4th Cir. 1985); see also Thomas v. Arn , 474 U.S. 140 (1985). Schoonover has waived appellate review by failing to file objections after receiving proper notice. Accordingly, we affirm the judgment of the district court. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
EXHIBIT 10.4


March 7, 2012


 


 


Vivian Liu


c/o Innovus Pharmaceuticals, Inc.


80 W. Sierra Madre Blvd., #392


Sierra Madre, CA 91024


 


Dear Ms. Liu:


 


We are pleased to offer you the position of
President & Chief Executive Officer of Innovus Pharmaceuticals, Inc., and its wholly-owned subsidiary, FasTrack Pharmaceuticals,
Inc., (together, the “Company”).


 


The following are your compensation terms:


 


Annual Salary:


 


You are entitled to receive $150,000, which
will commence when the Company raises an aggregate of $500,000, and will be retroactive to January 1, 2012. Excluded from the calculation
are the promissory notes issued by the Company in 2011.


 


Annual Bonus:


 


You are eligible to receive an Annual Bonus
targeted at 30% of your base salary, which is typically paid out in the first quarter following the bonus year.


 


Benefits:


 


You are entitled to medical and dental coverage
and any other Benefits offered by the Company. Until the Company sets-up its own plan, the Company will reimburse you for your
COBRA coverage from your previous employer.


 


You are entitled to 22 vacation days per year,
which will commence with your Annual Salary. You will receive an additional 2 vacation days for each additional year of service
at the Company.


 





T:
(626) 241-2094 • F:
(626) 604-3399 • www.innovuspharma.com
• 80 W. Sierra Madre Blvd., #392
• Sierra Madre, CA 91024




 






    	 



    	 



    
 


	 	2	




 


Stock Compensation Targets:


 


Based on your holdings of 833,669 shares of
the Company’s common stock, par value $0.001 per share, (the “Common Stock”), you are entitled to receive additional
Common Stock that would give you 4%, and 6% ownership of the Company on December 31, 2012 and December 31, 2013, respectively,
calculated based on shares outstanding on a fully-diluted basis.


 


The Stock Compensation Targets excludes any
Common Stock that you acquire in the open market or as a direct investment in the Company.


 


The achievement of the Stock Compensation Targets
assumes your continuous and uninterrupted employment with the Company.


 


Employment Contract:


 


The Board agrees to enter into an expanded Employment
Contract with you when the Company raises gross proceeds of $4 million or more.


 


Sincerely yours,


  


 


/s/ Ziad Mirza


Ziad Mirza, MD


Chairman of the Board


 


 


Accepted on 7th day of March, 2012


 


 


/s/ Vivian Liu


Vivian Liu
No. 11-7054 (11A432).

#### Frank Martinez Garcia, Petitioner v. Texas.

565 U.S. 972, 132 S. Ct. 474,

181 L. Ed. 2d 309,

2011 U.S. LEXIS 7597.

October 27, 2011.

Application for stay of execution of sentence of death, presented to Justice Scalia, and by him referred to the Court, denied. Petition for writ of certiorari to the Court of Criminal Appeals of Texas denied.
Exhibit 32.2




CERTIFICATION
PURSUANT TO


18 U.S.C.
SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the quarterly report of Infosmart Group, Inc. (the “Company”) on
Form 10-Q for the six months period ending June 30, 2009 as filed with the
Securities and Exchange Commission (the “Report”), I, Po Nei Sze, Chief
Financial Officer (Principal Financial Officer) of the Company, hereby certify
as of the date hereof, solely for purposes of Title 18, Chapter 63,
Section 1350 of the United States Code, that to the best of my
knowledge:




(1) The
Report fully complies with the requirements of Section 13(a) or 15(d), as
applicable, of the Securities Exchange Act of 1934, as amended, and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company at the dates
and for the periods indicated.




Date:
      August 15, 2009
              
              /s/
      Po Nei SzePo
      Nei SzeChief
      Financial Officer
                (Principal
      Financial Officer)




A signed
original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
```

[Federal Register Volume 76, Number 142 (Monday, July 25, 2011)]
[Notices]
[Page 44307]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-18808]

=======================================================================

-----------------------------------------------------------------------

CONSUMER PRODUCT SAFETY COMMISSION

Sunshine Act Meetings

FEDERAL REGISTER CITATION OF PREVIOUS ANNOUNCEMENT: Vol. 76, No. 140, 

Thursday July 21, 2011, page 43659.

ANNOUNCED TIME AND DATE OF OPEN MEETING: 10-11 a.m., Wednesday July 27, 

2011.

CHANGES TO OPEN MEETING: TIME CHANGE to 10 a.m.-12 p.m. REVISED AGENDA: 

Matters to be Considered: (1) Decisional Matters: (a) Phthalates notice 

of requirements; (b) Phthalates enforcement policy; (c) 100ppm lead 

enforcement statement; (2) Briefing Matter: Virginia Graeme Baker Pool 

and Spa Safety Act; Incorporation by reference of ANSI successor 

standard.

ANNOUNCED TIME AND DATE OF CLOSED MEETING: 11 a.m.-12 p.m., Wednesday 

July 27, 2011.

CHANGES TO CLOSED MEETING: TIME CHANGE to 2-3p.m.

    For a recorded message containing the latest agenda information, 

call (301) 504-7948.

CONTACT PERSON FOR ADDITIONAL INFORMATION: Todd A. Stevenson, Office of 

the Secretary, 4330 East West Highway, Bethesda, MD 20814 (301) 504-

7923.

    Dated: July 21, 2011.

Todd A. Stevenson,

Secretary.

[FR Doc. 2011-18808 Filed 7-21-11; 11:15 am]

BILLING CODE 6355-01-P
```
DEFENSE LOGISTICS AGENCY
ENERGY
8725 JOHN J. KINGMAN ROAD
FORT BELVOIR, VIRGINIA 22060-6222

February 24, 2017

MEMORANDUM FOR ALL FEDERAL CIVILIAN AND NON-DOD CUSTOMERS

SUBJECT: Defense Logistics Agency (DLA) Energy Cost Plus Rate

This memorandum provides the official Cost Plus Rate for DLA Energy petroleum products
managed under the Defense Working Capital Fund for fiscal year 2017 as $0.04 per gallon. The
rate published is intended to remain in effect throughout the fiscal year. The FY 2018 Cost Plus
Rate will be $0.045 per gallon.

Thank you in advance for your support to make our mission successful. Support to our
customers with the highest quality, priority service and lowest price is our top priority and
utmost concern.

Should you have any questions, please contact Mr. Joe Wilburn II at (703) 767-9454.

RICHARD R. SNINSKY
Director (Acting)
DLA Finance Energy
H. R. 3304 

One Hundred Sixteenth Congress 

of the 

United States of America 

AT THE FIRST SESSION 

Begun and held at the City of Washington on Thursday, 

the third day of January, two thousand and nineteen 

An Act 

To exempt for an additional 4-year period, from the application of the meanstest presumption of abuse under chapter 7, qualifying members of reserve components of the Armed Forces and members of the National Guard who, after September 11, 2001, are called to active duty or to perform a homeland defense 

activity for not less than 90 days. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. SHORT TITLE. 

This Act may be cited as the ‘‘National Guard and Reservists 

Debt Relief Extension Act of 2019’’. 

SEC. 2. NATIONAL GUARD AND RESERVISTS DEBT RELIEF AMENDMENT. 

Section 4(b) of the National Guard and Reservists Debt Relief 

Act of 2008 (Public Law 110–438; 122 Stat. 5000) is amended 

by striking ‘‘11-year’’ and inserting ‘‘15-year’’. 

SEC. 3. DETERMINATION OF BUDGETARY EFFECTS. 

The budgetary effects of this Act, for the purpose of complying 

with the Statutory Pay-As-You-Go Act of 2010, shall be determined 

by reference to the latest statement titled ‘‘Budgetary Effects of 

PAYGO Legislation’’ for this Act, submitted for printing in the 

Congressional Record by the Chairman of the House Budget Committee, provided that such statement has been submitted prior 

to the vote on passage. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.
PETER ALLEN 

Is being inducted into the Defense Industrial Supply Center Hall of Fame this twentieth day of 

January 1999 for his extraordinary leadership and support as the Deputy Director of the Product 

Services Integrated Process Unit and for his continuous outstanding mission support throughout 

his tenure at DISC from 1975 to 1993. 

Mr. Allen was instrumental in the development of the Federal Cataloging System Training Program, 

a multi-level program consisting of 44 separate modules designed to provide broad-spectrum 

coverage of cataloging policies, principles and theory. He played a vital role in the modernization of 

the Standard Automated Material Management System (SAMMS). A member of the Concept 

Development Group for SAMMS modernization, he was also responsible for management concept, 

data base and management requirement development for Technical, Engineering and Cataloging. 

Hall of Fame Inductees Page 1 of 1

https://www.troopsupport.dla.mil/about_us/pallen.htm 2/3/2016
[Federal Register Volume 63, Number 143 (Monday, July 27, 1998)]
[Notices]
[Page 40101]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-19905]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration


University of California, San Diego; Notice of Decision on 
Application for Duty-Free Entry of Scientific Instrument

    This decision is made pursuant to Section 6(c) of the Educational, 
Scientific, and Cultural Materials Importation Act of 1966 (Pub. L. 89-
651, 80 Stat. 897; 15 CFR part 301). Related records can be viewed 
between 8:30 a.m. and 5:00 p.m. in Room 4211, U.S. Department of 
Commerce, 14th and Constitution Avenue, NW, Washington, DC.
    Docket Number: 98-029. Applicant: University of California, San 
Diego, San Diego, CA 92121. Instrument: Wave Measurement Equipment. 
Manufacturer: Datawell bv, The Netherlands. Intended Use: See notice at 
63 FR 31737, June 10, 1998.
    Comments: None received. Decision: Approved. No instrument of 
equivalent scientific value to the foreign instrument, for such 
purposes as it is intended to be used, is being manufactured in the 
United States. Reasons: The foreign instrument provides: (1) more 
reliable wave direction estimates at frequencies under 1.0 Hz and over 
3.0 Hz with less variability within the range, and (2) better wave 
spread estimates than comparable domestic equipment. Two domestic 
manufacturers of similar equipment advised April 23, 1997 that (1) 
these capabilities are pertinent to the applicant's intended purpose 
and (2) they know of no domestic instrument or apparatus of equivalent 
scientific value to the foreign instrument for the applicant's intended 
use (comparable case).
    We know of no other instrument or apparatus of equivalent 
scientific value to the foreign instrument which is being manufactured 
in the United States.
Frank W. Creel,
Director, Statutory Import Programs Staff.
[FR Doc. 98-19905 Filed 7-24-98; 8:45 am]
BILLING CODE 3510-DS-P
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3305 Reported in Senate (RS)]

<DOC>

                                                       Calendar No. 162
116th CONGRESS
  1st Session
                                H. R. 3305

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 18, 2019

Received; read twice and referred to the Committee on Homeland Security 
                        and Governmental Affairs

                             July 24, 2019

               Reported by Mr. Johnson, without amendment

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
 at 2509 George Mason Drive in Virginia Beach, Virginia, as the ``Ryan 
                   Keith Cox Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. RYAN KEITH COX POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 2509 George Mason Drive in Virginia Beach, Virginia, shall 
be known and designated as the ``Ryan Keith Cox Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Ryan Keith 
Cox Post Office Building''.
                                                       Calendar No. 162

116th CONGRESS

  1st Session

                               H. R. 3305

_______________________________________________________________________

                                 AN ACT

 To designate the facility of the United States Postal Service located 
 at 2509 George Mason Drive in Virginia Beach, Virginia, as the ``Ryan 
                   Keith Cox Post Office Building''.

_______________________________________________________________________

                             July 24, 2019

                       Reported without amendment
```
No. 11-547 (R46-003).

#### HCP, Inc., fka Health Care Property Investors, Inc., Petitioner v. Ventas, Inc.

565 U.S. 1031, 132 S. Ct. 572,

181 L. Ed. 2d 418,

2011 U.S. LEXIS 8079.

November 9, 2011.

The petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit in the above-entitled case was dismissed today pursuant to Rule 46.1 of the rules of this Court.

Same case below, 647 F.3d 291.